Evolution of hemoglobinopathy diagnosis over 30 years in southern Spain: impact of migration and laboratory screening strategies
Laboratory Medicine · 04.08.2026 · 57 (5)
DOI: 10.1093/labmed/lmag045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, online erschienen am 04.08.2026. Verfasst von María-Angustias Molina-Arrebola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Haematology and Haemotherapy Unit, Biotechnology Department, Hospital Universitario Poniente, El Ejido, Almería, Spain. Hauptthemen laut MEDLINE: Hemoglobinopathies. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Hemoglobinopathies are a heterogeneous group of inherited disorders whose prevalence and phenotypic spectrum are influenced by population dynamics and diagnostic strategies. Longitudinal data from nonendemic European regions remain scarce.
Methods
We conducted a retrospective longitudinal analysis of hemoglobinopathies diagnosed at a regional hospital in southern Spain over a 30-year period (1996-2025). Diagnoses were classified as thalassemia syndromes or structural hemoglobin variants and analyzed according to the native or migrant origin of the patient. Temporal trends were assessed in relation to demographic changes and evolving laboratory methods.
Results
A total of 5340 hemoglobinopathies were identified: 1716 (32.1%) thalassemias and 3624 (67.9%) structural variants. Migrant patients accounted for 83.8% of diagnoses. Thalassemias predominated among native patients (88.1%), whereas structural variants, particularly hemoglobin S, predominated in migrant patients (78.6%). Annual diagnoses increased more than 5-fold during the study period, particularly after systematic high-performance liquid chromatography screening was introduced in 2008, with cases among migrant patients showing a strong linear trend (R2 = 0.86).
Discussion
This 30-year experience demonstrates a major shift in the epidemiology and diagnosis of hemoglobinopathies in southern Spain. Migration and advances in laboratory diagnostics have increased the detection of structural variants and complex genotypes, highlighting the need for continuously updated diagnostic algorithms in increasingly diverse populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Haematology and Haemotherapy Unit, Biotechnology Department, Hospital Universitario Poniente, El Ejido, Almería, Spain.
- Clinical Analysis Unit, Biotechnology Department, Hospital Universitario Poniente, El Ejido, Almería, Spain.
ORCID-Profile: María-Angustias Molina-Arrebola
Zitieren
APA
Molina-Arrebola, M. A., Sánchez-Crespo, A., Alarcón-Gallo, A. M., Porrino-Herrera, C., Martínez-Carreras, L., & González-Oller, C. (2026). Evolution of hemoglobinopathy diagnosis over 30 years in southern Spain: impact of migration and laboratory screening strategies. Laboratory Medicine, 57(5). https://doi.org/10.1093/labmed/lmag045
Vancouver
Molina-Arrebola MA, Sánchez-Crespo A, Alarcón-Gallo AM, Porrino-Herrera C, Martínez-Carreras L, González-Oller C. Evolution of hemoglobinopathy diagnosis over 30 years in southern Spain: impact of migration and laboratory screening strategies. Laboratory Medicine. 2026;57(5). doi:10.1093/labmed/lmag045
BibTeX
@article{MolinaArrebola2026,
author = {Molina-Arrebola, María-Angustias and Sánchez-Crespo, Alicia and Alarcón-Gallo, Ana-María and Porrino-Herrera, Carmen and Martínez-Carreras, Lucía and González-Oller, Carlos},
title = {Evolution of hemoglobinopathy diagnosis over 30 years in southern Spain: impact of migration and laboratory screening strategies},
journal = {Laboratory Medicine},
year = {2026},
volume = {57},
number = {5},
doi = {10.1093/labmed/lmag045}
}
EUVIMED